Neogen (NASDAQ:NEOG) is scheduled to post its quarterly earnings results before the market opens on Wednesday, January 3rd. Analysts expect Neogen to post earnings of $0.34 per share for the quarter.
Neogen (NASDAQ:NEOG) last announced its quarterly earnings data on Tuesday, September 19th. The company reported $0.31 EPS for the quarter, beating the Zacks’ consensus estimate of $0.30 by $0.01. The business had revenue of $95.30 million during the quarter, compared to analyst estimates of $94.87 million. Neogen had a net margin of 12.28% and a return on equity of 9.93%. The firm’s revenue for the quarter was up 14.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.26 earnings per share. On average, analysts expect Neogen to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Neogen (NEOG) opened at $82.89 on Wednesday. The company has a market cap of $3,151.66, a PE ratio of 69.66, a PEG ratio of 4.19 and a beta of 1.54. Neogen has a 52-week low of $59.51 and a 52-week high of $85.89.
Several research analysts recently issued reports on NEOG shares. Zacks Investment Research lowered shares of Neogen from a “buy” rating to a “hold” rating in a research report on Wednesday, November 1st. Roth Capital started coverage on shares of Neogen in a research report on Tuesday, December 5th. They issued a “neutral” rating and a $82.00 price target for the company. Finally, Craig Hallum increased their price target on shares of Neogen from $62.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, December 7th. Five investment analysts have rated the stock with a hold rating, The stock has a consensus rating of “Hold” and an average price target of $85.00.
In other news, insider James L. Herbert sold 26,000 shares of the firm’s stock in a transaction that occurred on Monday, November 13th. The shares were sold at an average price of $81.45, for a total transaction of $2,117,700.00. Following the completion of the sale, the insider now owns 879,430 shares of the company’s stock, valued at $71,629,573.50. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Steven J. Quinlan sold 2,250 shares of the firm’s stock in a transaction that occurred on Wednesday, October 4th. The stock was sold at an average price of $78.52, for a total transaction of $176,670.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 119,988 shares of company stock valued at $9,486,610. Company insiders own 4.20% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This article was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this article can be accessed at https://www.com-unik.info/2017/12/27/neogen-neog-to-release-earnings-on-wednesday.html.
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.
What are top analysts saying about Neogen? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Neogen and related companies.